Summary:
Sam Altman returns as OpenAI CEO, but board shakeup continues. His return sparks office celebrations but also lingering questions around OpenAI's profit model.
OpenAI researchers warned board of powerful AI discovery threatening humanity prior to Altman's initial ouster.
Lawmakers request SEC investigation into whether Elon Musk misled investors on safety of Neuralink brain implants.
Meet Matthew Butterick, leading lawsuits against major AI companies from OpenAI to Meta.
Gene editing advances with first gene-edited drug approved in UK, US may follow.
Astronauts share how they celebrate Thanksgiving in space.